Back to top
more

Agilon Health (AGL)

(Real Time Quote from BATS)

$5.38 USD

5.38
2,232,307

+0.04 (0.75%)

Updated Apr 24, 2024 09:36 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

5-Strong Sell of 5         5

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value D Growth C Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 36% (91 out of 252)

Industry: Medical Services

Better trading starts here.

Zacks News

New Strong Sell Stocks for March 25th

T, AGL and ALTO have been added to the Zacks Rank #5 (Strong Sell) List on March 25, 2023.

New Strong Sell Stocks for March 15th

AGL, BFIN and SNBR have been added to the Zacks Rank #5 (Strong Sell) List on March 15, 2024.

New Strong Sell Stocks for February 28th

AGL, BELFB and DRVN have been added to the Zacks Rank #5 (Strong Sell) List on February 28, 2023.

Agilon (AGL) Reports Q4 Earnings: What Key Metrics Have to Say

The headline numbers for Agilon (AGL) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Agilon Health (AGL) Reports Q4 Loss, Tops Revenue Estimates

Agilon (AGL) delivered earnings and revenue surprises of -46.43% and 0.72%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

Seeking Clues to Agilon (AGL) Q4 Earnings? A Peek Into Wall Street Projections for Key Metrics

Beyond analysts' top -and-bottom-line estimates for Agilon (AGL), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended December 2023.

Analysts Estimate Agilon Health (AGL) to Report a Decline in Earnings: What to Look Out for

Agilon (AGL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Is VanEck Morningstar International Moat ETF (MOTI) a Strong ETF Right Now?

Smart Beta ETF report for MOTI

Compared to Estimates, Agilon (AGL) Q3 Earnings: A Look at Key Metrics

Although the revenue and EPS for Agilon (AGL) give a sense of how its business performed in the quarter ended September 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Agilon (AGL) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

While the top- and bottom-line numbers for Agilon (AGL) give a sense of how the business performed in the quarter ended June 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Agilon Health (AGL) Reports Q2 Loss, Tops Revenue Estimates

Agilon (AGL) delivered earnings and revenue surprises of -300% and 3.39%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Strength Seen in Sotera Health Company (SHC): Can Its 17.3% Jump Turn into More Strength?

Sotera Health Company (SHC) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Agilon Health (AGL) Surpasses Q1 Earnings and Revenue Estimates

Agilon (AGL) delivered earnings and revenue surprises of 33.33% and 5.25%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

The Zacks Analyst Blog Highlights Humana, Viatris, agilon health and Cano Health

Humana, Viatris, agilon health and Cano Health are included in this Analyst Blog.

Kaibalya Pravo Dey headshot

4 Healthcare Stocks Poised to Beat Q1 Earnings Estimates

Growing patient volumes, admissions, health awareness and technological improvement in the first quarter are likely to have aided healthcare players like Humana (HUM), Viatris (VTRS), agilon health (AGL) and Cano Health (CANO).

Implied Volatility Surging for agilon health (AGL) Stock Options

Investors need to pay close attention to agilon health (AGL) stock based on the movements in the options market lately.

Agilon Health (AGL) Reports Q4 Loss, Tops Revenue Estimates

Agilon (AGL) delivered earnings and revenue surprises of -75% and 3.52%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Agilon Health (AGL) Reports Q3 Loss, Tops Revenue Estimates

Agilon (AGL) delivered earnings and revenue surprises of -40% and 6.70%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Charles River Laboratories (CRL) Beats Q2 Earnings Estimates

Charles River (CRL) delivered earnings and revenue surprises of 1.09% and 2.54%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?